ISIS Pharmaceuticals Inc $31.88

up +0.26


30/7/2014 04:00 PM  |  NASDAQ : ISIS  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get ISIS Trend Analysis - it has underperformed the S&P 500 by 4%

Partner Headlines

  1. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-APO(a) Rx In Patients ...

    Benzinga
  2. Markets Edge Higher; Alcoa Profit Beats Street View

    Benzinga
  3. US Stock Futures Edge Higher Ahead Of ADP Report

    Benzinga
  4. Isis Pharmaceuticals Earns $1M From GSK For Advancing Hepatitis B Virus ...

    Benzinga
  5. Benzinga's Top #PreMarket Losers

    Benzinga
  6. Brent Steady As Iraqi Exports Look Unaffected

    Benzinga
  7. Brent Retreats As Supply Interruption Worries Fade

    Benzinga
  8. Brent Up To $115 As ISIS Moves Toward Baghdad

    Benzinga
  9. Brent Climbs As Iraqi Oil Supplies Are Threatened

    Benzinga
  10. ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart Attack Drug

    Benzinga
  11. Morning Market Movers

    Benzinga
  12. UPDATE: Isis Pharmaceuticals Earns $10M Milestone Payment from Biogen Idec

    Benzinga
  13. US Stock Futures Decline Ahead Of Economic Data

    Benzinga
  14. Isis Pharma Announces Final Phase 2 Data on ISIS-GCGR Rx Showing Significant ...

    Benzinga
  15. Morning Market Movers

    Benzinga
  16. US Stock Futures Down Ahead Of Wholesale Trade Data

    Benzinga
  17. US Stock Futures Slightly Lower Ahead Of McDonald's Sales Report

    Benzinga
  18. Mid-Day Market Update: Fossil Drops On Downbeat Outlook; SunOpta Shares ...

    Benzinga
  19. Mid-Morning Market Update: Markets Open Lower; Macy's Posts Rise In Profit

    Benzinga
  20. Morning Market Movers

    Benzinga
  21. Benzinga's Top #PreMarket Gainers

    Benzinga
  22. US Stock Futures Edge Lower Ahead Of Producer Price Index

    Benzinga
  23. UPDATE: Piper Jaffray Upgrades ISIS Pharmaceuticals Following Mixed 1Q ...

    Benzinga
  24. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga
  25. Mid-Day Market Update: Twitter Drops On Earnings; Pepco Shares Gain

    Benzinga
  26. Isis Pharmaceuticals Shares Dropping Futher After Company released Updated ...

    Benzinga
  27. UPDATE: Isis Pharma Offers Updated Results from ISIS-SMN Rx Clinical Studies

    Benzinga
  28. Isis Pharmaceuticals to Present ISIS-SMN Rx Data at 2014 AAN Annual Meeting

    Benzinga
  29. Isis Reports Final Phase 2 Data on ISIS-APOCIII Rx

    Benzinga
  30. EARLIER: Isis Announces Antisense Targeting of HBV Produces Dose-Dependent ...

    Benzinga
  31. BioMed Realty Trust Leases Space To Life Science Firms

    IBD
  32. US Stock Futures Edge Higher; All Eyes On Fed

    Benzinga
  33. US Stock Futures Tumble Ahead Of Economic Data

    Benzinga
  34. Earnings Scheduled For February 28, 2014

    Benzinga
  35. Mid-Afternoon Market Update: Groupon Shares Continue to Show Weakness Following ...

    Benzinga
  36. Mid-Day Market Update: Acacia Research Shares Decline On Downbeat Results; ...

    Benzinga
  37. US Stock Futures Rise Ahead Of Existing-Home Sales Data

    Benzinga
  38. Isis Pharmaceuticals Earns $2M Milestone Payment from GSK for Advancement ...

    Benzinga
  39. UPDATE: Piper Jaffray Assumes Coverage on ISIS Pharmaceuticals as Company's ...

    Benzinga
  40. Isis Pharmaceuticals Initiates Phase 1 Study of ISIS-GSK3 Rx, Earns $3M ...

    Benzinga
  41. Isis Pharmaceuticals Announces Plan Investigate Higher Dose of ISIS-SMN ...

    Benzinga
  42. Isis Pharmaceuticals Announces Fifth Positive Phase 2 Data Set for ISIS-APOCIII ...

    Benzinga
  43. Isis Pharmaceuticals Announces Positive Phase 1 Results with ISIS-APO(a) ...

    Benzinga
  44. Isis Pharmaceuticals Announces $1.5M Milestone Payment from Biogen Related ...

    Benzinga
  45. UPDATE: J.P. Morgan Initiates Coverage on Isis Pharmaceuticals, Awaiting ...

    Benzinga
  46. Benzinga's Top Initiations

    Benzinga
  47. ISIS Pharm Advances Phase 2 Study of ISIS-SMN Rx in Infants, Says Earns ...

    Benzinga
  48. Pharmaceutical Industry Expected To Collect Billions From Obamacare

    Benzinga
  49. Market Wrap For Monday, September 23: Markets Unmoved Despite Kenyan Terror

    Benzinga
  50. Mid-Afternoon Market Update: Celldex Therapeutics Rallies as Pandora Drops

    Benzinga
Trading Center